Event Description: Sepsis and antimicrobial resistance (AMR) are closely and challengingly linked. Broad-spectrum antimicrobials are often the first line of defense in treating patients with sepsis, but limiting unnecessary antimicrobial usage is crucial for combatting the growing threat of AMR. As antimicrobial resistance worsens, more infections will develop into sepsis, sepsis cases will become increasingly difficult to treat, and more sepsis patients will suffer harmful consequences including amputations and death. To manage this complex clinical relationship, address the global threat…